218 related articles for article (PubMed ID: 22454080)
21. NT5E is associated with unfavorable prognosis and regulates cell proliferation and motility in gastric cancer.
Hu S; Meng F; Yin X; Cao C; Zhang G
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30992388
[TBL] [Abstract][Full Text] [Related]
22. Characterization of ectonucleotidases in human medulloblastoma cell lines: ecto-5'NT/CD73 in metastasis as potential prognostic factor.
Cappellari AR; Rockenbach L; Dietrich F; Clarimundo V; Glaser T; Braganhol E; Abujamra AL; Roesler R; Ulrich H; Battastini AM
PLoS One; 2012; 7(10):e47468. PubMed ID: 23094051
[TBL] [Abstract][Full Text] [Related]
23. MiR-422a promotes loco-regional recurrence by targeting NT5E/CD73 in head and neck squamous cell carcinoma.
Bonnin N; Armandy E; Carras J; Ferrandon S; Battiston-Montagne P; Aubry M; Guihard S; Meyronet D; Foy JP; Saintigny P; Ledrappier S; Jung A; Rimokh R; Rodriguez-Lafrasse C; Poncet D
Oncotarget; 2016 Jul; 7(28):44023-44038. PubMed ID: 27281619
[TBL] [Abstract][Full Text] [Related]
24. CD73/NT5E-mediated ubiquitination of AURKA regulates alcohol-related liver fibrosis via modulating hepatic stellate cell senescence.
Liu Z; Wu B; Liu X; Wu X; Du J; Xia G; Cai J; Zhu H; Sheng X; Zhang M; Xu J; Xu T; Lv X
Int J Biol Sci; 2023; 19(3):950-966. PubMed ID: 36778123
[TBL] [Abstract][Full Text] [Related]
25. 1α, 25-Dihydroxyvitamin D3 alters ectonucleotidase expression and activity in human cutaneous melanoma cells.
Bagatini MD; Bertolin K; Bridi A; Pelinson LP; da Silva Rosa Bonadiman B; Pillat MM; Gonçalves PBD; Ulrich H; Schetinger MRC; Morsch VM
J Cell Biochem; 2019 Jun; 120(6):9992-10000. PubMed ID: 30548323
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of NT5E/CD73 in neuroblastoma and its function in CSC stemness maintenance.
Jain D; Somasundaram DB; Aravindan S; Yu Z; Baker A; Esmaeili A; Aravindan N
Cell Biol Toxicol; 2023 Jun; 39(3):967-989. PubMed ID: 34773529
[TBL] [Abstract][Full Text] [Related]
27. NT5E upregulation in head and neck squamous cell carcinoma: A novel biomarker on cancer-associated fibroblasts for predicting immunosuppressive tumor microenvironment.
Chen XM; Liu YY; Tao BY; Xue XM; Zhang XX; Wang LL; Zhong H; Zhang J; Yang SM; Jiang QQ
Front Immunol; 2022; 13():975847. PubMed ID: 36091055
[TBL] [Abstract][Full Text] [Related]
28. Ecto-5'-nucleotidase/CD73 contributes to the radiosensitivity of T24 human bladder cancer cell line.
Dietrich F; Figueiró F; Filippi-Chiela EC; Cappellari AR; Rockenbach L; Tremblay A; de Paula PB; Roesler R; Filho AB; Sévigny J; Morrone FB; Battastini AMO
J Cancer Res Clin Oncol; 2018 Mar; 144(3):469-482. PubMed ID: 29305710
[TBL] [Abstract][Full Text] [Related]
29. CD73 acts as a prognostic biomarker and promotes progression and immune escape in pancreatic cancer.
Chen Q; Pu N; Yin H; Zhang J; Zhao G; Lou W; Wu W
J Cell Mol Med; 2020 Aug; 24(15):8674-8686. PubMed ID: 32643277
[TBL] [Abstract][Full Text] [Related]
30. Methylation of the calcium channel regulatory subunit α2δ-3 (CACNA2D3) predicts site-specific relapse in oestrogen receptor-positive primary breast carcinomas.
Palmieri C; Rudraraju B; Monteverde M; Lattanzio L; Gojis O; Brizio R; Garrone O; Merlano M; Syed N; Lo Nigro C; Crook T
Br J Cancer; 2012 Jul; 107(2):375-81. PubMed ID: 22644305
[TBL] [Abstract][Full Text] [Related]
31. Methylated tissue factor pathway inhibitor 2 (TFPI2) DNA in serum is a biomarker of metastatic melanoma.
Lo Nigro C; Wang H; McHugh A; Lattanzio L; Matin R; Harwood C; Syed N; Hatzimichael E; Briasoulis E; Merlano M; Evans A; Thompson A; Leigh I; Fleming C; Inman GJ; Proby C; Crook T
J Invest Dermatol; 2013 May; 133(5):1278-85. PubMed ID: 23407390
[TBL] [Abstract][Full Text] [Related]
32. Potential prognostic biomarker CD73 regulates epidermal growth factor receptor expression in human breast cancer.
Zhi X; Wang Y; Yu J; Yu J; Zhang L; Yin L; Zhou P
IUBMB Life; 2012 Nov; 64(11):911-20. PubMed ID: 23086814
[TBL] [Abstract][Full Text] [Related]
33. Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis.
Chatterjee A; Stockwell PA; Ahn A; Rodger EJ; Leichter AL; Eccles MR
Oncotarget; 2017 Jan; 8(4):6085-6101. PubMed ID: 28030832
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic silencing of novel tumor suppressors in malignant melanoma.
Muthusamy V; Duraisamy S; Bradbury CM; Hobbs C; Curley DP; Nelson B; Bosenberg M
Cancer Res; 2006 Dec; 66(23):11187-93. PubMed ID: 17145863
[TBL] [Abstract][Full Text] [Related]
35. NT5E mutations that cause human disease are associated with intracellular mistrafficking of NT5E protein.
Fausther M; Lavoie EG; Goree JR; Baldini G; Dranoff JA
PLoS One; 2014; 9(6):e98568. PubMed ID: 24887587
[TBL] [Abstract][Full Text] [Related]
36. Expression and clinical significance of serum NT5E protein in patients with colorectal cancer.
Wang G; Fu S; Li D; Chen Y
Cancer Biomark; 2019; 24(4):461-468. PubMed ID: 30932882
[TBL] [Abstract][Full Text] [Related]
37. Aberrant p27Kip1 promoter methylation in malignant melanoma.
Worm J; Bartkova J; Kirkin AF; Straten P; Zeuthen J; Bartek J; Guldberg P
Oncogene; 2000 Oct; 19(44):5111-5. PubMed ID: 11042700
[TBL] [Abstract][Full Text] [Related]
38. CD73 promotes proliferation and migration of human cervical cancer cells independent of its enzyme activity.
Gao ZW; Wang HP; Lin F; Wang X; Long M; Zhang HZ; Dong K
BMC Cancer; 2017 Feb; 17(1):135. PubMed ID: 28202050
[TBL] [Abstract][Full Text] [Related]
39. NT5E mutations and arterial calcifications.
St Hilaire C; Ziegler SG; Markello TC; Brusco A; Groden C; Gill F; Carlson-Donohoe H; Lederman RJ; Chen MY; Yang D; Siegenthaler MP; Arduino C; Mancini C; Freudenthal B; Stanescu HC; Zdebik AA; Chaganti RK; Nussbaum RL; Kleta R; Gahl WA; Boehm M
N Engl J Med; 2011 Feb; 364(5):432-42. PubMed ID: 21288095
[TBL] [Abstract][Full Text] [Related]
40. Expression of ecto-5'-nucleotidase (eN, CD73) in cell lines from various stages of human melanoma.
Sadej R; Spychala J; Skladanowski AC
Melanoma Res; 2006 Jun; 16(3):213-22. PubMed ID: 16718268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
